Cirrhosis is a common final pathway for most chronic liver diseases; representing an
increasing burden worldwide and is associated with increased morbidity and mortality …

It is well established that interleukin (IL)‐22 has hepatoprotective and antifibrotic functions in
acute liver injury models; however, its function in patients with liver fibrosis and liver cirrhosis …

Abstract T helper 17 (Th17) cells are a newly identified subset of T helper cells that play
important roles in host defense against extracellular bacteria, as well as in the pathogenesis …

Hepatitis C virus causes significant morbidity and mortality worldwide. The infection induces
upregulation of cytokine and chemokines commonly linked to the development of cellular …

Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …

Inflammatory immune cells can modulate activation of hepatic stellate cells (HSCs) and
progression of liver fibrosis. Type 3 inflammation characterized by production of interleukin …

The type 3 cytokines IL-17 and IL-22 play a crucial, well synchronized physiological role in
wound healing and repairing tissue damage due to infections or injury at barrier surfaces …

The proinflammatory cytokines transforming growth factor beta 1 (TGF-β1) and interleukin
(IL)-31 have been implicated in tissue injury. However, whether TGF-β1/IL-31 are stimulated …

Abstract T helper 9 (Th9) cells, a recently recognized Th cell subset, are involved in
autoimmune diseases. We aimed to investigate the role of Th9/interleukin-9 (IL-9) in the …

Abstract Introduction The interleukin-33/interleukin-13 pathway is involved in the
immunopathology of liver fibrosis and recently characterized group 2 innate lymphoid cells …